Diana Ruffato Resende Campanholi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diana Ruffato Resende Campanholi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Aparecida Marques
Ribeirão Preto Regional Center of Hematology National Institute of Science and Technology in Cell Therapy and Cell Therapy Center Ribeirão Preto Brazil
1 shared publication - Ana Vitoria Barban Margutti
Pediatrics Department, Ribeirão Preto Medical School University of São Paulo Ribeirão Preto Brazil
1 shared publication - Daniel Fantozzi Garcia
Ultragenyx Pharmaceutical, Inc. Novato California USA
1 shared publication - Ester S. Borges
School of Medicine Federal University of São Carlos São Carlos Brazil
1 shared publication - Fernanda Sperb-Ludwig
Postgraduate Program in Genetics and Molecular Biology Federal University of Rio Grande do Sul (UFRGS) Porto Alegre Rio Grande do Sul Brazil
1 shared publication - Gabriela Castro
Nutrition and Food Technology Institute Chile University Santiago Chile
1 shared publication
Latest Publications
- Open Access
- 6 May 2021
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 9 (5) , e1616
Molecular basis of various forms of maple syrup urine disease in Chilean patients
Background: Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disorder caused by the deficient activity of the branched‐chain α‐keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by four genes: BCKDHA, BCKDHB, DBT, and DLD. MSUD is predominantly caused by mutations in the BCKDHA, BCKDHB, and DBT genes which encode the E1α, E1β, and E2 subunits of the BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD in a cohort of Chilean MSUD patients by identifying point mutations in the BCKDHA, BCKDHB, and DBT genes and to describe their impact on the phenotypic heterogeneity of these patients.Methods: This manuscript describes a cross‐sectional study of 18 MSUD patients carried out using PCR and DNA sequencing.Results: Four novel pathogenic mutations were identified: one in BCKDHA (p.Thr338Ile), two in BCKDHB (p.Gly336Ser e p.Pro240Thr), and one in DBT (p.Gly406Asp). Four additional pathogenic mutations found in this study have been described previously. There were no correlations between the genotype and phenotype of the patients.Conclusion: If MSUD is diagnosed earlier, with a newborn screening approach, it might be possible to establish genotype‐phenotype relationships more efficiently.
- 6 May 2021
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 9 (5) , e1616
Open AccessMolecular basis of various forms of maple syrup urine disease in Chilean patients
Background: Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disorder caused by the deficient activity of the branched‐chain α‐keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by four genes: BCKDHA, BCKDHB, DBT, and DLD. MSUD is predominantly caused by mutations in the BCKDHA, BCKDHB, and DBT genes which encode the E1α, E1β, and E2 subunits of the BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD in a cohort of Chilean MSUD patients by identifying point mutations in the BCKDHA, BCKDHB, and DBT genes and to describe their impact on the phenotypic heterogeneity of these patients.Methods: This manuscript describes a cross‐sectional study of 18 MSUD patients carried out using PCR and DNA sequencing.Results: Four novel pathogenic mutations were identified: one in BCKDHA (p.Thr338Ile), two in BCKDHB (p.Gly336Ser e p.Pro240Thr), and one in DBT (p.Gly406Asp). Four additional pathogenic mutations found in this study have been described previously. There were no correlations between the genotype and phenotype of the patients.Conclusion: If MSUD is diagnosed earlier, with a newborn screening approach, it might be possible to establish genotype‐phenotype relationships more efficiently.